Global Blood Typing, Grouping and Infectious Disease Screening Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4564308
  • Report
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A
  • Immucor, Inc.
  • MORE
Blood Typing, Grouping and Infectious Disease Screening Market - Growth, Future Prospects and Competitive Analysis, 2018-2026, the global blood typing, grouping and infectious disease screening market was valued at US$ 3,079.8 Mn in 2017 and expected to reach US$ 7,078.3 Mn by 2026, expanding at a CAGR of 9.7% from 2018 to 2026.

Market Insights
The global blood typing, grouping and infectious disease screening market is projected to reach US$ 7,078.3 Mn by 2026 from US$ 3,079.8 Mn in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026. The factors contributing to the market growth includes increase in disposable income, rising population, growing awareness regarding blood donations and blood products. According to the Centers for Disease Control and Prevention, the cases of syphilis, a disease caused by Treponema pallidum, has increased by 17.6% in 2016 accounting for 8.7 cases per 100,000 population in the United States. Furthermore, the growing rate of infections catalyze the market growth. According to the HIV.gov (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary’s Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported around 36.7 million globally among which 2.1 million patients are less than 15 years of age. The global incident cases of HIV in 2016 was reported around 1.8 million that makes around 5,000 infections per day. The global blood typing, grouping and infectious disease screening market is segmented based on the test type, product type, infectious agent, and geography.

Based on the test type, the global market is segmented into ABO grouping, immunoassay screening and nucleic acid testing (NAT). In 2017, the market was dominated by the ABO grouping segment owing to the growing demand for blood & blood products, growing number of trauma cases and increasing usage of ABO blood grouping across other industries. Furthermore, NAT segment is identified as the fastest growing segment during the forecast period from 2018 to 2026. Based on the product type, the global market is segmented into kits, consumables and instruments. In 2017, consumables segment led the global market. Based on the infectious agent, the cytomegalovirus (CMV) led the market in 2017 owing to huge burden of infection cases.

Based the geographical segmentation, in 2017, North America led the global market with over 34% of the share, in terms of value. The supremacy of North America is attributed to the awareness among public regarding blood donations and infectious diseases. Furthermore, the treatment cost is higher compared to other parts of the world thereby making NA contribute majorly by value as compared to other regions. Asia Pacific is identified as the fastest growing region during the forecast period followed by the Latin America. Developing countries in these regions are the most potential markets such as India and Brazil that offers huge opportunities to the manufacturers.

The market is highly fragmented due to presence of several local and international manufacturers. No clear market leader is identified and the shares are distributed among the key players present in the market. The international players accounted more share than local players due to high market penetration, vast geographical outreach and diverse product portfolio. The key players in the market include Abbot Laboratories, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Grifols S.A, Immucor, Inc., Ortho Clinical Diagnostics, Quotient Ltd., and Thermo Fisher Scientific, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A
  • Immucor, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I - Secondary Research
1.4.2. Phase II - Primary Research
1.4.3. Phase III - Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Blood Typing, Grouping and Infectious Disease Screening Market Portraiture
2.2. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2017 (US$ Mn)
2.3. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2017 (US$ Mn)
2.4. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2017 (US$ Mn)
2.5. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Blood Typing, Grouping and Infectious Disease Screening Market: Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Incidence of Viral Infections
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. ABO Grouping
4.3. Immunoassay Screening
4.4. Nucleic Acid Testing (NAT)

Chapter 5. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Instruments
5.3. Consumables
5.4. Kits

Chapter 6. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Hepatitis B Virus (HBV)
6.3. Hepatitis C Virus (HCV)
6.4. Human Immunodeficiency Virus (HIV)
6.5. Human T-Lymphotropic Virus (HTLV)
6.6. Treponema pallidum (T. palladium)
6.7. Trypanosoma cruzi (T. cruzi)
6.8. West Nile Virus (WNV)
6.9. Cytomegalovirus (CMV)
6.10. Other Agents (Parvovirus, Ebola Virus, etc.)

Chapter 7. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
7.2.1. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
7.2.2. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
7.2.3. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.2.4. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Country, 2016 - 2026 (US$ Mn)
7.2.4.1. United States
7.2.4.2. Canada
7.3. Europe Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
7.3.1. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
7.3.2. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
7.3.3. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.3.4. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Country/Region, 2016 - 2026 (US$ Mn)
7.3.4.1. United Kingdom
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
7.4.1. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
7.4.2. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
7.4.3. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.4.4. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Country/Region, 2016 - 2026 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of Asia Pacific
7.5. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
7.5.1. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
7.5.2. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
7.5.3. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Type, 2016 - 2026 (US$ Mn)
7.5.4. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Country/Region, 2016 - 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
7.6.1. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
7.6.2. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
7.6.3. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.6.4. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Region, 2016 - 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Becton, Dickinson and Company
8.3. bioMérieux SA
8.4. Bio-Rad Laboratories, Inc.
8.5. DiaSorin S.p.A
8.6. F. Hoffmann-La Roche Ltd.
8.7. Grifols S.A
8.8. Immucor, Inc.
8.9. Ortho Clinical Diagnostics
8.10. Quotient Ltd.
8.11. Thermo Fisher Scientific, Inc.

List of Figures
FIG. 1 Market Segmentation: Global Blood Typing, Grouping and Infectious Disease Screening Market
FIG. 2 Research Methodology: Global Blood Typing, Grouping and Infectious Disease Screening Market
FIG. 3 Global Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2017 (US$ Mn)
FIG. 4 Global Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2017 (US$ Mn)
FIG. 6 Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2017
FIG. 8 Competitive Landscape: Global Blood Typing Grouping and Infectious Disease Screening Market, by Key Players, 2017
FIG. 9 Global ABO Grouping Market for Blood Typing, Grouping and Infectious Disease Screening, 2016 - 2026 (US$ Mn)
FIG. 10 Global Immunoassay Screening Market for Blood Typing, Grouping and Infectious Disease Screening, 2016 - 2026 (US$ Mn)
FIG. 11 Global Nucleic Acid Testing (NAT) Market for Blood Typing, Grouping and Infectious Disease Screening, 2016 - 2026 (US$ Mn)
FIG. 12 Global Instruments Market for Blood Typing, Grouping and Infectious Disease Screening, 2016 - 2026 (US$ Mn)
FIG. 13 Global Consumables Market for Blood Typing, Grouping and Infectious Disease Screening, 2016 - 2026 (US$ Mn)
FIG. 14 Global Kits Market for Blood Typing, Grouping and Infectious Disease Screening, 2016 - 2026 (US$ Mn)
FIG. 15 Global Blood Typing, Grouping and Infectious Disease Screening Market for Hepatitis B Virus (HBV), 2016 - 2026 (US$ Mn)
FIG. 16 Global Blood Typing, Grouping and Infectious Disease Screening Market for Hepatitis C Virus (HCV), 2016 - 2026 (US$ Mn)
FIG. 17 Global Blood Typing, Grouping and Infectious Disease Screening Market for Human Immunodeficiency Virus (HIV), 2016 - 2026 (US$ Mn)
FIG. 18 Global Blood Typing, Grouping and Infectious Disease Screening Market for Human T-Lymphotropic Virus (HTLV), 2016 - 2026 (US$ Mn)
FIG. 19 Global Blood Typing, Grouping and Infectious Disease Screening Market for Treponema pallidum (T. palladium), 2016 - 2026 (US$ Mn)
FIG. 20 Global Blood Typing, Grouping and Infectious Disease Screening Market for Trypanosoma cruzi (T. cruzi), 2016 - 2026 (US$ Mn)
FIG. 21 Global Blood Typing, Grouping and Infectious Disease Screening Market for West Nile virus (WNV), 2016 - 2026 (US$ Mn)
FIG. 22 Global Blood Typing, Grouping and Infectious Disease Screening Market for Cytomegalovirus (CMV), 2016 - 2026 (US$ Mn)
FIG. 23 Global Blood Typing, Grouping and Infectious Disease Screening Market for Other Agents, 2016 - 2026 (US$ Mn)
FIG. 24 United States Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 25 Canada Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 26 United Kingdom Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 27 Germany Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 28 Rest of Europe Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 29 Japan Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 30 China Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 31 Rest of Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 32 Brazil Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 33 Mexico Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 34 Rest of Latin America Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 35 GCC Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)
FIG. 36 Rest of Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, 2016 - 2026 (US$ Mn)

List of Tables
TABLE 1. Global Blood Typing, Grouping and Infectious Disease Screening Market Portraiture
TABLE 2. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 3. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 4. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 5. Global Blood Typing, Grouping and Infectious Disease Screening Market, by Geography, 2016 - 2026 (US$ Mn)
TABLE 6. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 7. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 8. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 9. North America Blood Typing, Grouping and Infectious Disease Screening Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 10. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 11. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 12. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 13. Europe Blood Typing, Grouping and Infectious Disease Screening Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 14. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 15. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 16. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 17. Asia Pacific Blood Typing, Grouping and Infectious Disease Screening Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 18. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 19. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 20. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Disease, 2016 - 2026 (US$ Mn)
TABLE 21. Latin America Blood Typing, Grouping and Infectious Disease Screening Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 22. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 23. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 24. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 25. Middle East & Africa Blood Typing, Grouping and Infectious Disease Screening Market, by Region, 2016 - 2026 (US$ Mn)
TABLE 26. Abbot Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27. Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28. bioMérieux SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29. Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30. DiaSorin S.p.A: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31. F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32. Grifols S.A: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33. Immucor, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34. Ortho Clinical Diagnostics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35. Quotient Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36. Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A
  • Immucor, Inc.
  • Ortho Clinical Diagnostics
  • Quotient Ltd.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll